International seroepidemiology of adenovirus serotypes 5, 26, 35, and 48 in pediatric and adult populationsDan H. Barouch, Jaap Goudsmit, David Ng’ang’a et al.|Vaccine|2011Cited by 308
Role of Transmitted Gag CTL Polymorphisms in Defining Replicative Capacity and Early HIV-1 PathogenesisJessica Prince, Eric Hunter, Daniel T. Claiborne et al.|PLoS Pathogens|2012Cited by 95
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 PreventionLindsey R. Baden, Etienne Karita, Gaudensia Mutua et al.|Annals of Internal Medicine|2016Cited by 84
Cumulative Impact of Host and Viral Factors on HIV-1 Viral-Load Control during Early InfectionLing Yue, Eric Hunter, Heather A. Prentice et al.|Journal of Virology|2012Cited by 54